- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
LeMaitre Vascular Inc(LMAT)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for LMAT
11/13/2026: LMAT (1-star) is a SELL. SELL for 3 days. Simulated Profits (-5.95%). Updated daily EoD!
LeMaitre Vascular Inc is a medical device company that designs and markets specialized products for vascular surgery. The company benefits from a dedicated direct sales force, high gross margins, and a resilient portfolio anchored by products like the XenoSure patch. Its primary growth strategy revolves around organic market expansion and disciplined tuck-in acquisitions of niche surgical lines. Key risks include revenue concentration, regulatory compliance hurdles, and the gradual shift toward minimally invasive endovascular procedures. The stock suits growth-oriented or moderate-risk investors seeking exposure to specialized medical technology, with ongoing attention required on organic revenue trends and integration milestones.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Offers steady, reliable organic growth rather than hyper-growth characteristics. |
| Momentum investor | Strong fit while signal remains positive | Suits momentum strategies conditional on a strong upward price trend and positive quarterly earnings surprises. |
| Value investor | Mixed fit | Valuation multiples often reflect consistent profitability, making it less of a classic deep-value play. |
| Dividend investor | Mixed fit | Provides regular dividend income, though yields are typically modest relative to traditional income stocks. |
| Low-risk investor | Medium | Exhibits moderate market volatility and solid balance sheet health, though small-cap medical device risk remains. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | As a smaller-cap medical device stock, shares can experience sharper price swings during broader market corrections. |
| Valuation risk | Medium | Trading at premium earnings multiples leaves little room for operational missteps or earnings misses. |
| Competition risk (large medtech conglomerates) | Medium | Well-capitalized larger competitors could attempt to encroach on core niche product markets. |
| Business quality | Strong | High gross margins and clean balance sheet underscore robust underlying franchise quality. |
| Dividend income | Low | Dividend payouts are safe but yield lower cash return relative to capital appreciation objectives. |
| Execution risk | Medium | Successful integration of tuck-in acquisitions and new product launches is vital for sustaining long-term growth. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.79B USD | Price to earnings Ratio 28.47 | 1Y Target Price 99.29 |
Price to earnings Ratio 28.47 | 1Y Target Price 99.29 | ||
Volume (30-day avg) 281.4K shares | Beta 0.49 | 52 Weeks Range 77.46 - 117.37 | Updated Date 11/15/2026 |
52 Weeks Range 77.46 - 117.37 | Updated Date 11/15/2026 | ||
Dividends yield (FY) 1.22% | Basic EPS (TTM) 2.75 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Instruments & Supplies
- BUY participation
- 60.0%
- Active BUY / eligible
- 3 / 5
- 30-Day BUY Count Change
- +1
Eligible universe: 5 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -28.78% | Avg. Invested days 36 | Today’s Advisory SELL |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Vascular Devices | Sales of biological grafts, patches like XenoSure, shunts, and catheters used primarily in open vascular procedures. | This is the primary earnings engine of the company, driven by recurring surgical product demand. |
| Geographic Operations (North America & International) | Direct sales operations spanning the United States, Europe, and Asia Pacific. | Geographic diversification helps cushion regional economic downturns and expands the addressable customer base. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-04 | When After Market | Estimate 0.69 | Actual 0.65 |
Profitability
Profit Margin 23.51% | Operating Margin (TTM) 24.69% |
Management Effectiveness
Return on Assets (TTM) 6.63% | Return on Equity (TTM) 15.62% |
Valuation
Trailing PE 28.47 | Forward PE 24.94 | Enterprise Value 1.59B | Price to Sales(TTM) 6.65 |
Enterprise Value 1.59B | Price to Sales(TTM) 6.65 | ||
Enterprise Value to Revenue 5.9 | Enterprise Value to EBITDA 16.24 | Shares Outstanding 22.88M | Shares Floating 21.31M |
Shares Outstanding 22.88M | Shares Floating 21.31M | ||
Percent Insiders 8.05 | Percent Institutions 103.81 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

